23536
Bluelight Crew
- Joined
- Dec 16, 2010
- Messages
- 7,725
Testosterone replacement has long been prescribed for men who suffer from abnormally low levels of the male sex hormone, but overuse can lead to infertility and can even speed the growth of prostate cancer.
That hasn't stopped Michael Murray, a healthy 43-year-old home stager who works in New York and Chicago, from getting frequent testosterone injections to raise his energy level and give his bodybuilding regime a boost.
"Am I making a deal with the devil? A little bit, but I have to think about my quality of life," Murray explains. "It is like I'm in my 20s again."
In what may become one of the most sought-after lifestyle drugs since the introduction of Pfizer's Viagra 14 years ago, new testosterone drugs from Eli Lilly, Abbott Laboratories, and other drugmakers are hot. Prescriptions for testosterone replacement therapies have more than doubled since 2006 to 5.6 million last year, according to data compiled by Bloomberg. Sales are expected to triple to $5 billion by 2017, forecasts Global Industry Analysts.
Read more: http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2012/05/12/BUTB1OGKII.DTL#ixzz1uoNozJ8z
That hasn't stopped Michael Murray, a healthy 43-year-old home stager who works in New York and Chicago, from getting frequent testosterone injections to raise his energy level and give his bodybuilding regime a boost.
"Am I making a deal with the devil? A little bit, but I have to think about my quality of life," Murray explains. "It is like I'm in my 20s again."
In what may become one of the most sought-after lifestyle drugs since the introduction of Pfizer's Viagra 14 years ago, new testosterone drugs from Eli Lilly, Abbott Laboratories, and other drugmakers are hot. Prescriptions for testosterone replacement therapies have more than doubled since 2006 to 5.6 million last year, according to data compiled by Bloomberg. Sales are expected to triple to $5 billion by 2017, forecasts Global Industry Analysts.
Read more: http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2012/05/12/BUTB1OGKII.DTL#ixzz1uoNozJ8z